← Leaderboards
Xavier Grana
Temple University
$5,217,972
Attributed
$5,789,484
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,789,484 · 11
By mechanism
R01$2,753,791 · 3
T32$1,143,025 · 1
U54$525,753 · 1
K02$522,450 · 1
R21$412,500 · 1
R41$203,744 · 1
Top collaborators
- Jonathan A Soboloff4 shared
- Kelly A Whelan1 shared
Most similar at Temple University
Same institution · by research overlap
- Dan A Liebermann$7,118,115
- Barbara Hoffman$2,389,437
Others in their field
Top investigators on “Cyclins”
- Piotr Sicinski · Dana-Farber Cancer Inst$42,699,610
- J. Alan Diehl · University Of Nebraska Medical Center$21,437,568
- Richard G Pestell · Yeshiva University$16,269,311
- Steven I Reed · Scripps Research Institute$16,177,190
- Bruce E Clurman · Fred Hutchinson Cancer Research Center$15,606,607
- David Owen Morgan · University Of California San Francisco$15,595,703
Research focus
CyclinsSignal TransductionHuman SubjectLeukocyte Activation /TransformationCyclin Dependent KinaseProteinsMediatingComplexGenesTrainingPhosphorylationPathway InteractionsPositioning AttributeMalignant NeoplasmsAffectClinical ResearchMacrophageCatalytic DomainT LymphocyteProtein DephosphorylationHiv InfectionsPhosphoric Monoester HydrolasesCell TypeBinding
Grant awards (29)
Molecular Biology and Genetics: Signaling, Epigenetics and Genome Maintenance$258,006
T32 · FY2025 · GM · contact PI
Research Education Core$245,705
U54 · FY2025 · CA · contact PI
PP2A/B55alpha substrate specificity and function in cell cycle progression$661,956
R01 · FY2024 · GM · contact PI
Research Education Core$280,048
U54 · FY2024 · CA · contact PI
Molecular Biology and Genetics: Signaling, Epigenetics and Genome Maintenance$266,352
T32 · FY2024 · GM · contact PI
Molecular Biology and Genetics: Signaling, Epigenetics and Genome Maintenance$255,057
T32 · FY2023 · GM · contact PI
Molecular Biology and Genetics: Signaling, Epigenetics and Genome Maintenance$248,953
T32 · FY2022 · GM · contact PI
Molecular Biology and Genetics: Signaling, Epigenetics and Genome Maintenance$114,657
T32 · FY2021 · GM · contact PI
Unraveling the complexity of substrate specificity of PP2A/B55a, a major eukaryote Serine/Threonine Phosphatase$310,372
R01 · FY2019 · GM · contact PI
Unraveling the complexity of substrate specificity of PP2A/B55a, a major eukaryote Serine/Threonine Phosphatase$310,372
R01 · FY2018 · GM · contact PI
PPP2R2A tumor suppression haploinsufficiency in prostate cancer$79,250
R03 · FY2018 · CA · contact PI
Unraveling the complexity of substrate specificity of PP2A/B55a, a major eukaryote Serine/Threonine Phosphatase$310,372
R01 · FY2017 · GM · contact PI
PPP2R2A tumor suppression haploinsufficiency in prostate cancer$79,250
R03 · FY2017 · CA · contact PI
Unraveling the complexity of substrate specificity of PP2A/B55a, a major eukaryote Serine/Threonine Phosphatase$321,152
R01 · FY2016 · GM · contact PI
Unraveling the complexity of substrate specificity of PP2A/B55a, a major eukaryote Serine/Threonine Phosphatase$90,000
R01 · FY2016 · GM · contact PI
Tat and CDK9 on gene expression alterations coupled to HIV-1 Associated Dementia$187,500
R21 · FY2010 · MH · contact PI
Tat and CDK9 on gene expression alterations coupled to HIV-1 Associated Dementia$225,000
R21 · FY2009 · MH · contact PI
Identification of Small Pharmacologic Inhibitors of HIV-1 Replication$203,744
R41 · FY2007 · MH · contact PI
T-TYPE CYCLIN/CDK9 COMPLEXES IN T CELL ACTIVATION$104,490
K02 · FY2004 · AI
T-TYPE CYCLIN/CDK9 COMPLEXES IN T CELL ACTIVATION$104,490
K02 · FY2003 · AI
T TYPE CYCLINS IN T CELL ACTIVATION/HIV REPLICATION$257,277
R01 · FY2002 · AI
T-TYPE CYCLIN/CDK9 COMPLEXES IN T CELL ACTIVATION$104,490
K02 · FY2002 · AI
Role of T type cyclins in T cell activation$0
M01 · FY2002 · RR
T TYPE CYCLINS IN T CELL ACTIVATION/HIV REPLICATION$249,783
R01 · FY2001 · AI
T-TYPE CYCLIN/CDK9 COMPLEXES IN T CELL ACTIVATION$104,490
K02 · FY2001 · AI
Role of T type cyclins in T cell activation$0
M01 · FY2001 · RR
T TYPE CYCLINS IN T CELL ACTIVATION/HIV REPLICATION$242,507
R01 · FY2000 · AI
T-TYPE CYCLIN/CDK9 COMPLEXES IN T CELL ACTIVATION$104,490
K02 · FY2000 · AI
REGULATION OF P130 DURING THE CELL CYCLE AND QUIESCENCE$69,721
R29 · FY2000 · GM